Assistant Professor, Medicine, University of Colorado School of Medicine
Gastroenterology
Dr. Scott Biggins, MD
|
|
Give Review
Dr. Scott Biggins is an expert in the field of Gastroenterology. He studied medicine at Keck School of Medicine of USC. Keck School of Medicine of USC has a rank of 31 in research and a 72 in primary care He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Scott Biggins is also a published doctor. He has 46 paper published. The most recent paper is: Sister chromatid cohesion in mitosis. He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
- Association Between Plasma Level of Galectin-9 and Survival of Patients With Drug-Induced Acute Liver Failure.
- This is a letter to the editor.
- Risk Factors Associated With Acute Heart Failure During Liver Transplant Surgery: A Case Control Study.
- Survival Benefit of Repeat Liver Transplantation in the United States: A Serial MELD Analysis by Hepatitis C Status and Donor Risk Index.
- Effect of the pretransplant serum sodium concentration on outcomes following liver transplantation.
- Stage of Cirrhosis predicts risk of liver related death in low MELD patients with Cirrhosis awaiting liver transplant.
- Rate and Predictors of Successful Cardiopulmonary Resuscitation in End-Stage Liver Disease.
- Survival in infection-related acute-on-chronic liver failure is defined by extra-hepatic organ failures.
- Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation.
- Kidney, pancreas and liver allocation and distribution in the United States.
- Simultaneous liver-kidney transplantation summit: current state and future directions.
- Retransplantation for hepatic allograft failure: prognostic modeling and ethical considerations.
- Should HCV-related Cirrhosis be a contraindication for retransplantation?
- Serum sodium predicts mortality in patients listed for liver transplantation.
- Treatment of recurrent Hepatitis C after liver transplantation.
- Management of recurrent Hepatitis C in liver transplant recipients.
- Evidence-based incorporation of serum sodium concentration into MELD.
- MELD-based liver allocation: who is underserved?
- How effective are 3-month and 12-month predictive models of mortality after first liver transplantation?
- Model for end-stage liver Disease (MELD) exception for ascites.
- In a MELD-based economy, how can we fight off inflation?
- Beyond the numbers: rational and ethical application of outcome models for organ allocation in liver transplantation.
- Retransplantation for Hepatitis C: results of a U.S. multicenter retransplant study.
- Inequities of the Model for End-Stage Liver Disease: an examination of current components and future additions.
- Hyponatremia and mortality among patients on the liver-transplant waiting list.
- Transplant tourism to China: the impact on domestic patient-care decisions.
- Impact of pretransplant hyponatremia on outcome following liver transplantation.
- Understanding liver health using the National Center for Health Statistics.
- New model for end stage liver disease improves prognostic capability after transjugular intrahepatic portoSystemic shunt.
- Reduced effectiveness of standard recruitment for deceased organ donor registration: the need for population-specific recruitment materials.
- Moderate ascites identifies patients with low model for end-stage liver Disease scores awaiting liver transplantation who have a high mortality risk.
- Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantation.
- Inoperable pancreatic cancer patients who have prolonged survival exhibit an increased risk of cholangitis.
- Decision making in liver transplant selection committees: a multicenter study.
- Pretransplant severe hepatic encephalopathy, peritransplant sodium and post-liver transplantation morbidity and mortality.
- Supply and demand in transplant tourism: disclosure duties of the transplant physician and our global transplant community.
- Predictors of endoscopic treatment outcomes in the management of Biliary problems after liver transplantation at a high-volume academic center.
- Ascites improves upon [corrected] serum sodium plus [corrected] model for end-stage liver Disease (MELD) for predicting mortality in patients with advanced liver Disease.
- Height contributes to the gender difference in wait-list mortality under the MELD-based liver allocation System.
- Survival benefit-based deceased-donor liver allocation.
- Sister chromatid cohesion in mitosis.
- Genes involved in sister chromatid separation and segregation in the budding yeast Saccharomyces cerevisiae.
- The conserved protein kinase Ipl1 regulates microtubule binding to kinetochores in budding yeast.
Schools
Keck School Of Medicine Of The University Of Southern California
Oregon Health amp Science University
University Of California San Francisco School Of Medicine Program
University Of California Los Angeles
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- ERCP (Endoscopic Retrograde Cholangiopancreatography)
- Liver Biopsy
Conditions Treated
- Abdominal Pain
- Anemia
- Benign Neoplasm of the Digestive System
- Biliary Atresia
- View All
Doctors Specialties
- Gastroenterology
- Transplant Hepatology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
UCSF -
Oregon Health & Science University -
Keck School of Medicine of USC
Hospital
-
University of Colorado Hospital
Drug Facts
| NPI NUMBER | 1861443145 | |
| NPPES Provider LastName | BIGGINS | |
| NPPES Provider FirstName | SCOTT | |
| NPPES Provider ZIPCode | 800452545 | |
| NPPES Provider State | CO | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 259.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1861443145 |
| Last Name Of The Provider | BIGGINS |
| First Name Of The Provider | SCOTT |
| View All |
Similar Doctors
|
Dr. George S. Chin, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. James R. Burton Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Gregory Everson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew J. Stotts, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Joel S. Levine, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Emily K. Ward, MD |
|
|
Dr. Amanda C. Wieland, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aimee E. Truesdale, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raj Shah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
David S. Law |